Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Biological Chemistry
|
September 2, 2004
New short splice variants of the human cardiac Cavbeta2 subunit: redefining the major functional motifs implemented in modulation of the Cav1.2 channel
Jo Beth Harry, Evgeny Kobrinsky, Darrell R Abernethy, et al.
Journal of Biomedical Semantics
|
December 20, 2012
A 2012 Workshop: Vaccine and Drug Ontology in the Study of Mechanism and Effect (VDOSME 2012)
Yongqun He, Luca Toldo, Gully Burns, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2004
Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique
Donald E Mager, Darrell R Abernethy, Josephine M Egan, et al.
Journal of Pharmaceutical Sciences
|
May 29, 2013
The utility of modeling and simulation in drug development and regulatory review
Shiew-Mei Huang, Darrell R Abernethy, Yaning Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 12, 2015
Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells
Vaishali L Chudasama, Meric A Ovacik, Darrell R Abernethy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2006
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit
Swasti Tiwari, Yuwei Zhang, Jennifer Heller, et al.
Journal of Clinical Pharmacology
|
February 5, 2011
Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages
Danijela Gnjidic, David G Le Couteur, Darrell R Abernethy, et al.
The Annals of Pharmacotherapy
|
September 30, 2010
A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people
Danijela Gnjidic, David G Le Couteur, Darrell R Abernethy, et al.
Personalized Medicine
|
May 24, 2018
Pharmacogenomics and adverse drug reactions
Shashi Amur, Issam Zineh, Darrell R Abernethy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 13, 2018
β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease
Naomi Gronich, Darrell R Abernethy, Eitan Auriel, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Biological Chemistry
|
September 2, 2004
New short splice variants of the human cardiac Cavbeta2 subunit: redefining the major functional motifs implemented in modulation of the Cav1.2 channel
Jo Beth Harry, Evgeny Kobrinsky, Darrell R Abernethy, et al.
Journal of Biomedical Semantics
|
December 20, 2012
A 2012 Workshop: Vaccine and Drug Ontology in the Study of Mechanism and Effect (VDOSME 2012)
Yongqun He, Luca Toldo, Gully Burns, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 17, 2004
Exendin-4 pharmacodynamics: insights from the hyperglycemic clamp technique
Donald E Mager, Darrell R Abernethy, Josephine M Egan, et al.
Journal of Pharmaceutical Sciences
|
May 29, 2013
The utility of modeling and simulation in drug development and regulatory review
Shiew-Mei Huang, Darrell R Abernethy, Yaning Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 12, 2015
Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells
Vaishali L Chudasama, Meric A Ovacik, Darrell R Abernethy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2006
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit
Swasti Tiwari, Yuwei Zhang, Jennifer Heller, et al.
Journal of Clinical Pharmacology
|
February 5, 2011
Drug burden index and beers criteria: impact on functional outcomes in older people living in self-care retirement villages
Danijela Gnjidic, David G Le Couteur, Darrell R Abernethy, et al.
The Annals of Pharmacotherapy
|
September 30, 2010
A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people
Danijela Gnjidic, David G Le Couteur, Darrell R Abernethy, et al.
Personalized Medicine
|
May 24, 2018
Pharmacogenomics and adverse drug reactions
Shashi Amur, Issam Zineh, Darrell R Abernethy, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 13, 2018
β2-adrenoceptor agonists and antagonists and risk of Parkinson's disease
Naomi Gronich, Darrell R Abernethy, Eitan Auriel, et al.
Page
of 6